{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:44:16Z","timestamp":1778813056246,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11882-021-00989-x","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T04:33:27Z","timestamp":1612931607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Management of Allergic Diseases During COVID-19 Outbreak"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6124-5197","authenticated-orcid":false,"given":"Adriana","family":"Izquierdo-Dom\u00ednguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Rojas-Lechuga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isam","family":"Alobid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,9]]},"reference":[{"issue":"2","key":"989_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jaci.2020.05.033","volume":"146","author":"K Hosoki","year":"2020","unstructured":"Hosoki K, Chakraborty A, Sur S. Molecular mechanisms and epidemiology of COVID-19 from an allergist\u2019s perspective. J Allergy Clin Immunol. 2020;146(2):285\u201399.","journal-title":"J Allergy Clin Immunol."},{"issue":"2","key":"989_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jaci.2020.06.010","volume":"146","author":"KD Chhiba","year":"2020","unstructured":"Chhiba KD, Patel GB, Vu THT, Chen MM, Guo A, Kudlaty E, et al. Prevalence and characterization of asthma in hospitalized and non-hospitalized patients with COVID-19. J Allergy Clin Immunol. 2020;146(2):307\u201314.e4.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"989_CR3","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.jaip.2020.03.012","volume":"8","author":"MS Shaker","year":"2020","unstructured":"Shaker MS, Oppenheimer J, Grayson M, Stukus D, Hartog N, Hsieh EWY, et al. COVID-19: pandemic contingency planning for the allergy and immunology clinic. J Allergy Clin Immunol Pract. 2020;8(5):1477\u201388.e5.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"989_CR4","doi-asserted-by":"publisher","unstructured":"\u2022 Olaguibel JM, Alobid I, Alvarez Puebla M, Crespo-Lessmann A, Dom\u00ednguez Ortega J, Garc\u00eda-Rio F, et al. Upper and lower airways functional examination in asthma and respiratory allergic diseases. Considerations in the SARS-CoV-2 post-pandemic situation. J Investig Allergol Clin Immunol. 2020. https:\/\/doi.org\/10.18176\/jiaci.0625COMMENT: this review shows the different examination techniques available on the assessment of patients suffering from respiratory allergy, asthma and associated diseases in the pandemic momentum.","DOI":"10.18176\/jiaci.0625"},{"key":"989_CR5","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Pfaar OKL, Klimek L, Jutel M, Akdis CA, Bousquet J, Breiteneder H, et al. COVID-19 pandemic: practical considerations on the organization of an allergy clinic an EAACI\/ARIA position paper. Allergy. 2020. https:\/\/doi.org\/10.1111\/all.14453COMMENT: this consensus document offers a prioritization rational to help guide decision making when such situations arise and an allergist\/immunologist is forced to reduce services or makes the de- cision on his or her own to do so.","DOI":"10.1111\/all.14453"},{"issue":"1 Suppl","key":"989_CR6","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1067\/mai.2001.115569","volume":"108","author":"DP Skoner","year":"2001","unstructured":"Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108(1 Suppl):S2\u20138.","journal-title":"J Allergy Clin Immunol."},{"issue":"4","key":"989_CR7","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jaci.2017.03.050","volume":"140","author":"JL Bro\u017cek","year":"2017","unstructured":"Bro\u017cek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950\u20138.","journal-title":"J Allergy Clin Immunol."},{"issue":"5","key":"989_CR8","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.jaip.2020.02.004","volume":"8","author":"J Mullol","year":"2020","unstructured":"Mullol J, Del Cuvillo A, Lockey RF. Rhinitis phenotypes. J Allergy Clin Immunol Pract. 2020;8(5):1492\u2013503.","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"4","key":"989_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4193\/Rhin17.074","volume":"55","author":"A Izquierdo-Dominguez","year":"2017","unstructured":"Izquierdo-Dominguez A, Jauregui I, Del Cuvillo A, Montoro J, Davila I, Sastre J, et al. Allergy rhinitis: similarities and differences between children and adults. Rhinology. 2017;55(4):326\u201331.","journal-title":"Rhinology."},{"issue":"Suppl 86","key":"989_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","volume":"63","author":"J Bousquet","year":"2008","unstructured":"Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(Suppl 86):8\u2013160.","journal-title":"Allergy"},{"issue":"3","key":"989_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jaci.2003.12.027","volume":"113","author":"TA Platts-Mills","year":"2004","unstructured":"Platts-Mills TA. Allergen avoidance. J Allergy Clin Immunol. 2004;113(3):388\u201391.","journal-title":"J Allergy Clin Immunol."},{"issue":"1","key":"989_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jaci.2019.06.049","volume":"145","author":"J Bousquet","year":"2020","unstructured":"Bousquet J, Sch\u00fcnemann HJ, Togias A, Bachert C, Erhola M, Hellings PW, et al. Next-generation allergic rhinitis and its impact on asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70\u201380.e3.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"989_CR13","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaci.2020.08.008","volume":"146","author":"JM Yang","year":"2020","unstructured":"Yang JM, Koh HY, Moon SY, Yoo IK, Ha EK, You S, et al. Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study. J Allergy Clin Immunol. 2020;146(4):790\u20138.","journal-title":"J Allergy Clin Immunol."},{"issue":"5","key":"989_CR14","doi-asserted-by":"publisher","first-page":"100124","DOI":"10.1016\/j.waojou.2020.100124","volume":"13","author":"GK Scadding","year":"2020","unstructured":"Scadding GK, Hellings PW, Bachert C, Bjermer L, Diamant Z, Gevaert P, et al. Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement. World Allergy Organ J. 2020;13(5):100124.","journal-title":"World Allergy Organ J."},{"key":"989_CR15","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1111\/all.14302","volume":"75","author":"J Bousquet","year":"2020","unstructured":"Bousquet J, Akdis C, Jutel M, Bachert C, Klimek L, Agache I, et al. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement. Allergy. 2020;75:2440\u20134. https:\/\/doi.org\/10.1111\/all.14302.","journal-title":"Allergy."},{"issue":"7","key":"989_CR16","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/all.14336","volume":"75","author":"L Klimek","year":"2020","unstructured":"Klimek L, Jutel M, Akdis C, Bousquet J, Akdis M, Bachert C, et al. Handling of allergen immunotherapy in the COVID-19 pandemic: an ARIA-EAACI statement. Allergy. 2020;75(7):1546\u201354.","journal-title":"Allergy."},{"key":"989_CR17","doi-asserted-by":"publisher","unstructured":"\u2022 Hartmann-Boyce J, Gunnell J, Drake J, Otunla A, Suklan J, Schofield E, et al. Asthma and COVID-19: review of evidence on risks and management considerations. BMJ Evid Based Med. 2020. https:\/\/doi.org\/10.1136\/bmjebm-2020-111506COMMENT: In this review, the authors set out to review existing publications, preprints and national guidelines to answer the risk and management in asthmatic patients during the COVID-19 pandemic.","DOI":"10.1136\/bmjebm-2020-111506"},{"key":"989_CR18","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention, 2020. Available from: www.ginaasthma.org. Accesed 11 Nov 2020."},{"key":"989_CR19","unstructured":"Gu\u00eda Espa\u00f1ola para el Manejo del Asma (GEMA5.0). Global Strategy for Asthma Management, 2019. Available from: www.gemasma.com."},{"issue":"20","key":"989_CR20","doi-asserted-by":"publisher","first-page":"E551","DOI":"10.1503\/cmaj.200617","volume":"192","author":"EM Abrams","year":"2020","unstructured":"Abrams EM, \u2019t Jong GW, Yang CL. Asthma and COVID-19. CMAJ. 2020;192(20):E551.","journal-title":"CMAJ"},{"issue":"5","key":"989_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.18176\/jiaci.0595","volume":"30","author":"A Izquierdo-Dom\u00ednguez","year":"2020","unstructured":"Izquierdo-Dom\u00ednguez A, Rojas-Lechuga MJ, Chiesa-Estomba C, Calvo-Henr\u00edquez C, Ninchritz-Becerra E, Soriano-Reixach M, et al. Smell and taste dysfunction in COVID-19 is associated with younger age in ambulatory settings: a multicenter cross-sectional study. J Investig Allergol Clin Immunol. 2020;30(5):346\u201357.","journal-title":"J Investig Allergol Clin Immunol."},{"key":"989_CR22","unstructured":"Coronavirus Disease 2019 (COVID-19)-People with Certain Medical Conditions. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medicalconditions.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fneed-extra-precautions%2Fgroups-at-higher-risk.html. Last Updated Nov. 2, 2020. Content source: National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. Accesed 11 Nov 2020"},{"issue":"7821","key":"989_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430\u20136.","journal-title":"Nature."},{"key":"989_CR24","doi-asserted-by":"publisher","unstructured":"Bousquet J, Jutel M, Akdis CA, Klimek L, Pfaar O, Nadeau KC, et al. ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020). Allergy. 2020:2020. https:\/\/doi.org\/10.1111\/all.14471.","DOI":"10.1111\/all.14471"},{"issue":"8","key":"989_CR25","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/all.12429","volume":"69","author":"A Muraro","year":"2014","unstructured":"Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Beyer K, Bindslev-Jensen C, et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014;69(8):1008\u201325.","journal-title":"Allergy."},{"key":"989_CR26","doi-asserted-by":"publisher","unstructured":"Protudjer JLP, Golding M, Salisbury MR, Abrams EM, Roos LE. High anxiety andhealth-related quality of life in families with children with food allergy during coronavirus disease 2019. Ann Allergy Asthma Immunol. 2021:2020. https:\/\/doi.org\/10.1016\/j.anai.2020.09.010.","DOI":"10.1016\/j.anai.2020.09.010"},{"issue":"9","key":"989_CR27","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1016\/j.jaip.2020.07.020","volume":"8","author":"DP Mack","year":"2020","unstructured":"Mack DP, Chan ES, Shaker M, Abrams EM, Wang J, Fleischer DM, et al. Novel approaches to food allergy management during COVID-19 inspire long-term change. J Allergy Clin Immunol Pract. 2020;8(9):2851\u20137. https:\/\/doi.org\/10.1016\/j.jaip.2020.07.020.","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"1","key":"989_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/all.13562","volume":"74","author":"K Brockow","year":"2019","unstructured":"Brockow K, Ardern-Jones MR, Mockenhaupt M, Aberer W, Barbaud A, Caubet JC, et al. EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity. Allergy. 2019;74(1):14\u201327.","journal-title":"Allergy."},{"issue":"2","key":"989_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bpa.2020.05.004","volume":"34","author":"SS Patil","year":"2020","unstructured":"Patil SS, Sun L, Fox CJ, Anthony KE, Anzalone FA, Fisher PM, et al. Multiple drug allergies: recommendations for perioperative management. Best Pract Res Clin Anaesthesiol. 2020;34(2):325\u201344.","journal-title":"Best Pract Res Clin Anaesthesiol."},{"issue":"11","key":"989_CR30","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1111\/all.14439","volume":"75","author":"A Gelincik","year":"2020","unstructured":"Gelincik A, Brockow K, \u00c7elik GE, Do\u00f1a I, Mayorga C, Romano A, et al. Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: an EAACI position paper. Allergy. 2020;75(11):2775\u201393.","journal-title":"Allergy."},{"key":"989_CR31","doi-asserted-by":"publisher","unstructured":"\u2022 Dordal Culla MT, Herrera-Lasso Reg\u00e1s V, Mart\u00ed Garrido J, Rodr\u00edguez Cumplido D, V\u00e1zquez-Revuelta P, Lleonart Bellfill R. Treating COVID-19: review of drug hypersensitivity reactions. J Investig Allergol Clin Immunol. 2020. https:\/\/doi.org\/10.18176\/jiaci.0588COMMENT: the document summarizes current knowledge regarding mainly the immunological adverse drug reactions related to the drugs used for COVID-19, in order to address their management in a comprehensive manner for allergology study.","DOI":"10.18176\/jiaci.0588"},{"issue":"6","key":"989_CR32","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.1111\/jdv.16474","volume":"34","author":"A Est\u00e9banez","year":"2020","unstructured":"Est\u00e9banez A, P\u00e9rez-Santiago L, Silva E, Guillen-Climent S, Garc\u00eda-V\u00e1zquez A, Ram\u00f3n MD. Cutaneous manifestations in COVID-19: a new contribution. J Eur Acad Dermatol Venereol. 2020;34(6):e250\u20131.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"1","key":"989_CR33","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1016\/j.jaad.2020.04.094","volume":"83","author":"P Suchonwanit","year":"2020","unstructured":"Suchonwanit P, Leerunyakul K, Kositkuljorn C. Cutaneous manifestations in COVID-19: lessons learned from current evidence. J Am Acad Dermatol. 2020;83(1):e57\u201360.","journal-title":"J Am Acad Dermatol."},{"issue":"6","key":"989_CR34","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1111\/jdv.16411","volume":"34","author":"A Wollenberg","year":"2020","unstructured":"Wollenberg A, Flohr C, Simon D, Cork MJ, Thyssen JP, Bieber T, et al. European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis. J Eur Acad Dermatol Venereol. 2020;34(6):e241\u20132.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"7","key":"989_CR35","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.1111\/jdv.16527","volume":"34","author":"S Ferrucci","year":"2020","unstructured":"Ferrucci S, Romagnuolo M, Angileri L, Berti E, Tavecchio S. Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports. J Eur Acad Dermatol Venereol. 2020;34(7):e303\u20134.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"4","key":"989_CR36","doi-asserted-by":"publisher","first-page":"e13310","DOI":"10.1111\/dth.13310","volume":"33","author":"Y Yan","year":"2020","unstructured":"Yan Y, Chen H, Chen L, Cheng B, Diao P, Dong L, et al. Consensus of Chinese experts on protection of skin and mucous membrane barrier for health-care workers fighting against coronavirus disease 2019. Dermatol Ther. 2020;33(4):e13310.","journal-title":"Dermatol Ther."},{"key":"989_CR37","doi-asserted-by":"crossref","unstructured":"Bousquet J, Pfaar O, Togias A, Sch\u00fcnemann HJ, Ansotegui I, Papadopoulos NG, Tsiligianni I, Agache I, Anto JM, Bachert C, Bedbrook A, Bergmann KC, Bosnic-Anticevich S, Bosse I, Brozek J, Calderon MA, Canonica GW, Caraballo L, Cardona V, Casale T, Cecchi L, Chu D, Costa E, Cruz AA, Czarlewski W, Durham SR, du Toit G, Dykewicz M, Ebisawa M, Fauquert JL, Fernandez-Rivas M, Fokkens WJ, Fonseca J, Fontaine JF, Gerth van Wijk R, Haahtela T, Halken S, Hellings PW, Ierodiakonou D, Iinuma T, Ivancevich JC, Jacobsen L, Jutel M, Kaidashev I, Khaitov M, Kalayci O, Kleine Tebbe J, Klimek L, Kowalski ML, Kuna P, Kvedariene V, la Grutta S, Larenas-Linemann D, Lau S, Laune D, le L, Lodrup Carlsen K, Louren\u00e7o O, Malling HJ, Marien G, Menditto E, Mercier G, Mullol J, Muraro A, O\u2019Hehir R, Okamoto Y, Pajno GB, Park HS, Panzner P, Passalacqua G, Pham-Thi N, Roberts G, Pawankar R, Rolland C, Rosario N, Ryan D, Samolinski B, Sanchez-Borges M, Scadding G, Shamji MH, Sheikh A, Sturm GJ, Todo Bom A, Toppila-Salmi S, Valentin-Rostan M, Valiulis A, Valovirta E, Ventura MT, Wahn U, Walker S, Wallace D, Waserman S, Yorgancioglu A, Zuberbier T, the ARIA Working Group ARIA Working Group. 2019 ARIA Care pathways for allergen immunotherapy. Allergy. 2019;74(11):2087-2102.","DOI":"10.1111\/all.13805"},{"issue":"4","key":"989_CR38","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/all.13262","volume":"73","author":"GJ Sturm","year":"2018","unstructured":"Sturm GJ, Varga EM, Roberts G, Mosbech H, Bil\u00f2 MB, Akdis CA, et al. EAACI guidelines on allergen immunotherapy: hymenoptera venom allergy. Allergy. 2018;73(4):744\u201364.","journal-title":"Allergy."},{"key":"989_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5414\/ALX02147E","volume":"4","author":"L Klimek","year":"2020","unstructured":"Klimek L, Pfaar O, Worm M, Bergmann KC, Bieber T, Buhl R, et al. Allergen immunotherapy in the current COVID-19 pandemic: a position paper of AeDA, ARIA, EAACI, DGAKI and GPA: position paper of the German ARIA Group in cooperation with the Austrian ARIA Group, the Swiss ARIA, German Society for Applied Allergology (AEDA), German Society for Allergology and Clinical Immunology (DGAKI), Society for Pediatric Allergology (GPA) in cooperation with AG Clinical Immunology, Allergology and Environmental Medicine of the DGHNO-KHC, and the European Academy of Allergy and Clinical Immunology (EAACI). Allergol Select. 2020;4:44\u201352.","journal-title":"Allergol Select"},{"key":"989_CR40","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jaip.2020.09.050","volume":"9","author":"MJ Rial","year":"2020","unstructured":"Rial MJ, Valverde M, Del Pozo V, Gonz\u00e1lez-Barcala FJ, Mart\u00ednez-Rivera C, Mu\u00f1oz X, et al. Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak. J Allergy Clin Immunol Pract. 2020;9:487\u2013489.e1. https:\/\/doi.org\/10.1016\/j.jaip.2020.09.050.","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"4","key":"989_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5414\/ALX02166E","volume":"7","author":"L Klimek","year":"2020","unstructured":"Klimek L, Pfaar O, Worm M, Eiwegger T, Hagemann J, Ollert M, et al. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: position paper of \u00c4rzteverband Deutscher Allergologen (AeDA) A, Deutsche Gesellschaft f\u00fcr Allergologie und Klinische Immunologie (DGAKI) B, Gesellschaft f\u00fcr P\u00e4diatrische Allergologie und Umweltmedizin (GPA)C, \u00d6sterreichische Gesellschaft f\u00fcr Allergologie und Immunologie (\u00d6GAI) D, Luxemburgische Gesellschaft f\u00fcr Allergologie und Immunologie (LGAI) E, \u00d6sterreichische Gesellschaft f\u00fcr Pneumologie (\u00d6GP) F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI) H. Allergol Select. 2020;7(4):53\u201368.","journal-title":"Allergol Select"},{"key":"989_CR42","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/all.13319","volume":"73","author":"GB Pajno","year":"2018","unstructured":"Pajno GB, Fernandez-Rivas M, Arasi S, Roberts G, Akdis CA, Alvaro-Lozano M, et al. EAACI guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy. 2018;73:799\u2013815.","journal-title":"Allergy"},{"key":"989_CR43","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/all.13317","volume":"73","author":"G Roberts","year":"2018","unstructured":"Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, Gerth van Wijk R, et al. EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy. 2018;73:765\u201398.","journal-title":"Allergy."},{"key":"989_CR44","doi-asserted-by":"publisher","unstructured":"Carugno A, Raponi F, Locatelli AG, Vezzoli P, Gambini DM, Di Mercurio M, et al. No evidence of increased risk for coronavirus disease 2019 (COVID-19) in patients treated with dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy. J Eur Acad Dermatol Venereol. 2020. https:\/\/doi.org\/10.1111\/jdv.16552.","DOI":"10.1111\/jdv.16552"},{"issue":"1","key":"989_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1001\/jamadermatol.2019.3336","volume":"156","author":"EL Simpson","year":"2020","unstructured":"Simpson EL, Paller AS, Siegfried EC, Boguniewicz M, Sher L, Gooderham MJ, et al. Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis: a phase 3 randomized clinical trial. JAMA Dermatol. 2020;156(1):44\u201356.","journal-title":"JAMA Dermatol."},{"issue":"11","key":"989_CR46","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1111\/all.14407","volume":"75","author":"A Vultaggio","year":"2020","unstructured":"Vultaggio A, Agache I, Akdis CA, Akdis M, Bavbek S, Bossios A, et al. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: an EAACI statement. Allergy. 2020;75(11):2764\u201374.","journal-title":"Allergy."},{"issue":"5","key":"989_CR47","doi-asserted-by":"publisher","first-page":"100126","DOI":"10.1016\/j.waojou.2020.100126","volume":"13","author":"M Morais-Almeida","year":"2020","unstructured":"Morais-Almeida M, Aguiar R, Martin B, Ansotegui IJ, Ebisawa M, Arruda LK, et al. COVID-19, asthma, and biological therapies: what we need to know. World Allergy Organ J. 2020;13(5):100126.","journal-title":"World Allergy Organ J."}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-021-00989-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-021-00989-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-021-00989-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T22:14:13Z","timestamp":1614723253000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-021-00989-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["989"],"URL":"https:\/\/doi.org\/10.1007\/s11882-021-00989-x","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"13 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"8"}}